Cargando…

Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)

BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Kjell, Ställberg, Björn, Lisspers, Karin, Telg, Gunilla, Johansson, Gunnar, Thuresson, Marcus, Janson, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774144/
https://www.ncbi.nlm.nih.gov/pubmed/29347939
http://dx.doi.org/10.1186/s12931-018-0719-x
_version_ 1783293711537405952
author Larsson, Kjell
Ställberg, Björn
Lisspers, Karin
Telg, Gunilla
Johansson, Gunnar
Thuresson, Marcus
Janson, Christer
author_facet Larsson, Kjell
Ställberg, Björn
Lisspers, Karin
Telg, Gunilla
Johansson, Gunnar
Thuresson, Marcus
Janson, Christer
author_sort Larsson, Kjell
collection PubMed
description BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and managemant of severe asthma in a Swedish asthma popuöation. METHODS: In this observational cohort study, primary care medical records data (2006–2013) from 36 primary health care centers were linked to data from national mandatory Swedish health registries. The studied population (>18 years) had a record of drug collection for obstructive pulmonary disease (ATC code R03) during 2011–2012, and a physician diagnosed asthma (ICD-10 code J45-J46) prior to drug collection. Severe asthma was classified as collection of high dose inhaled steroid (> 800 budesonide or equivalent per day) and leukotriene receptor antagonist and/or long-acting beta-agonist. Poor asthma control was defined as either collection of ≥600 doses of short-acting beta-agonists, and/or ≥1 exacerbation(s) during the year post index date. RESULTS: A total of 18,724 asthma patients (mean 49 years, 62.8% women) were included, of whom 17,934 (95.8%) had mild to moderate and 790 (4.2%) had severe asthma. Exacerbations were more prevalent in severe asthma (2.59 [2.41–2.79], Relative Risk [95% confidence interval]; p < 0.001). Poor asthma control was observed for 28.2% of the patients with mild to moderate asthma and for more than half (53.6%) of the patients with severe asthma (<0.001). Prior to index, one in five severe asthma patients had had a contact with secondary care and one third with primary care. A concurrent COPD diagnosis increased disease burden. CONCLUSION: Severe asthma was found in 4.2% of asthma patients in Sweden, more than half of them had poor asthma control, and most patients had no regular health care contacts.
format Online
Article
Text
id pubmed-5774144
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57741442018-01-26 Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) Larsson, Kjell Ställberg, Björn Lisspers, Karin Telg, Gunilla Johansson, Gunnar Thuresson, Marcus Janson, Christer Respir Res Research BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and managemant of severe asthma in a Swedish asthma popuöation. METHODS: In this observational cohort study, primary care medical records data (2006–2013) from 36 primary health care centers were linked to data from national mandatory Swedish health registries. The studied population (>18 years) had a record of drug collection for obstructive pulmonary disease (ATC code R03) during 2011–2012, and a physician diagnosed asthma (ICD-10 code J45-J46) prior to drug collection. Severe asthma was classified as collection of high dose inhaled steroid (> 800 budesonide or equivalent per day) and leukotriene receptor antagonist and/or long-acting beta-agonist. Poor asthma control was defined as either collection of ≥600 doses of short-acting beta-agonists, and/or ≥1 exacerbation(s) during the year post index date. RESULTS: A total of 18,724 asthma patients (mean 49 years, 62.8% women) were included, of whom 17,934 (95.8%) had mild to moderate and 790 (4.2%) had severe asthma. Exacerbations were more prevalent in severe asthma (2.59 [2.41–2.79], Relative Risk [95% confidence interval]; p < 0.001). Poor asthma control was observed for 28.2% of the patients with mild to moderate asthma and for more than half (53.6%) of the patients with severe asthma (<0.001). Prior to index, one in five severe asthma patients had had a contact with secondary care and one third with primary care. A concurrent COPD diagnosis increased disease burden. CONCLUSION: Severe asthma was found in 4.2% of asthma patients in Sweden, more than half of them had poor asthma control, and most patients had no regular health care contacts. BioMed Central 2018-01-18 2018 /pmc/articles/PMC5774144/ /pubmed/29347939 http://dx.doi.org/10.1186/s12931-018-0719-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Larsson, Kjell
Ställberg, Björn
Lisspers, Karin
Telg, Gunilla
Johansson, Gunnar
Thuresson, Marcus
Janson, Christer
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title_full Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title_fullStr Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title_full_unstemmed Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title_short Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
title_sort prevalence and management of severe asthma in primary care: an observational cohort study in sweden (pacehr)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774144/
https://www.ncbi.nlm.nih.gov/pubmed/29347939
http://dx.doi.org/10.1186/s12931-018-0719-x
work_keys_str_mv AT larssonkjell prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT stallbergbjorn prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT lissperskarin prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT telggunilla prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT johanssongunnar prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT thuressonmarcus prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr
AT jansonchrister prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr